Healthcare firm eyes up further growth
Healthcare 21 Group is targeting significant European expansion after completing the purchase of Aquilant from H2 Equity Partners in a deal to create a £133m annual turnover business.
Healthcare 21, which has its UK head office in Leeds, sealed the deal after receiving approval from Ireland’s Competition and Consumer Protection Commission.
The expanded business will employ 450 staff and become the largest privatelyowned healthcare sales and marketing specialist in the UK and Ireland.
Healthcare 21, which has doubled in size in the past two years, is a specialist supplier of healthcare products and solutions.
Its customers include the HSE, the NHS, private hospitals, primary and community healthcare professionals and veterinary and pharmacy suppliers, and many of the largest medical OEMs and healthcare product businesses in the world. The firm said it also has a strong tech element to its business, having acquired two major online platforms selling and advising on a wide range of medical devices and healthcare products in the past 12 months.
As part of the new acquisition, H2 Equity Partners will become a substantial minority shareholder in the newly enlarged Healthcare 21 Group, which will focus on investing in Europe to drive future growth.
The firms said the combination of Healthcare 21 and Aquilant will create a new market leading group of specialist medical sales teams with an in-depth understanding of the healthcare market.
The immediate target for the new business will be to build on a substantial client base in the UK, Ireland, Germany and Austria.
Healthcare 21’s chairman Owen Curtin, inset, said: “There is a huge consolidation opportunity in European healthcare.”